Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rocco Giordano

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Biomedicines|August 29, 2024
Post-COVID-19 Pain Is Not Associated with DNA Methylation Levels of the <i>ACE2</i> Promoter in COVID-19 Survivors Hospitalized Due to SARS-CoV-2 InfectionCésar Fernández-de-Las-Peñas, Gema Díaz-Gil, Antonio Gil-Crujera, et al.
Viruses|February 24, 2024
Inflammatory Polymorphisms (IL-6 <i>rs1800796</i>, IL-10 <i>rs1800896</i>, TNF-α <i>rs1800629</i>, and IFITM3 <i>rs12252</i>) Are Not Associated with Post-COVID Symptoms in Previously Hospitalized COVID-19 SurvivorsCésar Fernández-de-Las-Peñas, Gema Díaz-Gil, Antonio Gil-Crujera, et al.
International Journal of Molecular Sciences|March 13, 2025
DNA Salivary Methylation Levels of the ACE2 Promoter Are Not Related to ACE2 (<i>rs2285666</i> and <i>rs2074192</i>), TMPRSS2 (<i>rs12329760</i> and <i>rs2070788</i>) and ACE1 <i>rs1799752</i> Polymorphisms in COVID-19 Survivors with Post-COVID-19 ConditionCésar Fernández-de-Las-Peñas, Gema Díaz-Gil, Antonio Gil-Crujera, et al.
Viruses|June 27, 2024
Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms?César Fernández-de-Las-Peñas, Anabel Franco-Moreno, María Ruiz-Ruigómez, et al.
Journal of Medical Virology|May 15, 2024
Presence of SARS-CoV-2 RNA in COVID-19 survivors with post-COVID symptoms 2 years after hospitalization: The VIPER studyCésar Fernández-de-Las-Peñas, Juan Torres-Macho, Maria Ruiz-Ruigómez, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Biomedicines|August 29, 2024
Post-COVID-19 Pain Is Not Associated with DNA Methylation Levels of the <i>ACE2</i> Promoter in COVID-19 Survivors Hospitalized Due to SARS-CoV-2 InfectionCésar Fernández-de-Las-Peñas, Gema Díaz-Gil, Antonio Gil-Crujera, et al.
Viruses|February 24, 2024
Inflammatory Polymorphisms (IL-6 <i>rs1800796</i>, IL-10 <i>rs1800896</i>, TNF-α <i>rs1800629</i>, and IFITM3 <i>rs12252</i>) Are Not Associated with Post-COVID Symptoms in Previously Hospitalized COVID-19 SurvivorsCésar Fernández-de-Las-Peñas, Gema Díaz-Gil, Antonio Gil-Crujera, et al.
International Journal of Molecular Sciences|March 13, 2025
DNA Salivary Methylation Levels of the ACE2 Promoter Are Not Related to ACE2 (<i>rs2285666</i> and <i>rs2074192</i>), TMPRSS2 (<i>rs12329760</i> and <i>rs2070788</i>) and ACE1 <i>rs1799752</i> Polymorphisms in COVID-19 Survivors with Post-COVID-19 ConditionCésar Fernández-de-Las-Peñas, Gema Díaz-Gil, Antonio Gil-Crujera, et al.
Viruses|June 27, 2024
Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms?César Fernández-de-Las-Peñas, Anabel Franco-Moreno, María Ruiz-Ruigómez, et al.
Journal of Medical Virology|May 15, 2024
Presence of SARS-CoV-2 RNA in COVID-19 survivors with post-COVID symptoms 2 years after hospitalization: The VIPER studyCésar Fernández-de-Las-Peñas, Juan Torres-Macho, Maria Ruiz-Ruigómez, et al.
Pageof 5